Form 8-K - Current report:
SEC Accession No. 0000950170-24-104550
Filing Date
2024-09-09
Accepted
2024-09-09 07:16:14
Documents
12
Period of Report
2024-09-09
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tern-20240909.htm   iXBRL 8-K 70797
2 EX-99.1 tern-ex99_1.htm EX-99.1 48195
  Complete submission text file 0000950170-24-104550.txt   252881

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tern-20240909.xsd EX-101.SCH 26982
14 EXTRACTED XBRL INSTANCE DOCUMENT tern-20240909_htm.xml XML 5119
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39926 | Film No.: 241285847
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)